A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...

A new study shows that those with cannabis use disorder (or an inability to stop using it despite health or social ...

What makes the human brain unique? A Yale study unlocks new insights into genetic changes that shaped our evolution.

Several factors can contribute to the development or triggering of schizophrenia, especially in individuals who are already at risk due to genetic or environmental factors. These include: ...

Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is ...

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

The Noonan lab at Yale University is focused on understanding how HARs contribute to the evolution of uniquely human brain features.